EPIRUBICIN SERVYCAL

Epirubicin Hydrochloride 10 mg

Epirubicin Hydrochloride 50 mg

LYOPHILIZED POWDER FOR INJECTION, FOR IV INFUSION

Sale under filed prescription

Made in Argentina

QUALI-QUANTITATIVE COMPOSITION:

Each vial of 10 mg contains:

Epirubicin hydrochloride 10 mg

Lactose monohydrate 50 mg

Each vial of 50 mg contains:

Epirubicin hydrochloride 50 mg

Lactose monohydrate 250 mg

THERAPEUTIC ACTION:

Citostatic.

INDICATIONS:

Epirubicin has been therapeutically effective in the treatment of the following malignancies: breast cancer, small-cell lung cancer, transitional cell bladder carcinoma, gastric cancer, ovarian cancer, soft tissue sarcoma, osteosarcoma, esophageal carcinoma, pancreatic carcinoma, primary hepatocellular carcinoma, head and neck carcinomas, non-Hodgkin's lymphoma, Hodgkin's lymphoma, acute lymphoblastic leukemia, acute leukemia, multiple myeloma, pediatric tumors.

PRESENTATION:

EPIRUBICINA SERVYCAL 10 mg: containing 1 vial.

EPIRUBICINA SERVYCAL 50 mg: containing 1 vial.

Keep between 15 °C and 25 °C, protect from light.